Larvol Delta - Clinical-trials-in-systemic-lupus-erythematosus-the-dilemmaWhy-have-phase-III-trials-failed-to-confirm-the-promising-results-of-phase-II-trials

Lupuzor (rigerimod) - ImmuPharma, Alora Pharma

Stelara (ustekinumab) - J&J

Epratucyn (epratuzumab) - Gilead

Olumiant (baricitinib) - Incyte, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/36202589

Oct 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next